Peripheral biomarkers of cognitive response to dopamine receptor agonist treatment

Psychopharmacology

Volumn 214, Issue 4, 2011, Pages 779-789

  Ersche, Karen D ^a,b   Roiser, Jonathan P ^c   Lucas, Mark ^d   Domenici, Enrico ^e   Robbins, Trevor W ^b,f   Bullmore, Edward T ^a,b,d  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

^d GLAXOSMITHKLINE   (United Kingdom)

^e GSK   (Italy)

^f UK   (United Kingdom)

Author keywords

COMT; Dopamine; DRD3; mRNA; Peripheral biomarker; Personalized medicine; Pramipexole; Spatial working memory; Stimulant dependence

Indexed keywords

BIOLOGICAL MARKER; CATECHOL METHYLTRANSFERASE; CENTRAL STIMULANT AGENT; DOPAMINE; DOPAMINE 3 RECEPTOR; DOPAMINE 4 RECEPTOR; MESSENGER RNA; PLACEBO; PRAMIPEXOLE;

ADULT; AMPHETAMINE DEPENDENCE; ARTICLE; CLINICAL ARTICLE; COCAINE DEPENDENCE; CONTROLLED STUDY; CROSSOVER PROCEDURE; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG BLOOD LEVEL; DRUG DEPENDENCE; FATIGUE; FEMALE; HUMAN; MALE; NAUSEA; NEUROPSYCHOLOGICAL TEST; NEUROTRANSMISSION; PREDICTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; SINGLE DRUG DOSE; SPATIAL MEMORY; SWEATING; TASK PERFORMANCE; TREATMENT RESPONSE; VISUAL ANALOG SCALE; VOMITING; WITHDRAWAL SYNDROME; WORKING MEMORY;

ADULT; AMPHETAMINE-RELATED DISORDERS; BENZOTHIAZOLES; BIOLOGICAL MARKERS; CATECHOL O-METHYLTRANSFERASE; COCAINE-RELATED DISORDERS; COGNITION; CROSS-OVER STUDIES; DOPAMINE AGONISTS; DOUBLE-BLIND METHOD; FEMALE; GENE EXPRESSION; HUMANS; MALE; MEMORY, SHORT-TERM; NEUROPSYCHOLOGICAL TESTS; PREDICTIVE VALUE OF TESTS; PROLACTIN; RECEPTORS, DOPAMINE D3; RECEPTORS, DOPAMINE D4; RNA, MESSENGER;

EID: 79953646050     PISSN: 00333158     EISSN: 14322072     Source Type: Journal    
DOI: 10.1007/s00213-010-2087-1     Document Type: Article

References (70)

1. Aharonovich E, Nunes E, Hasin D (2003) Cognitive impairment, retention and abstinence among cocaine abusers in cognitivebehavioral treatment. Drug Alcohol Depend 71:207-211 (Pubitemid 37289030)
2. American Psychiatric Association (2000) Diagnostic and Statistical Manual of Mental Disorders-4th Edition. American Psychiatric Association, Washington, DC, Text Revision
3. Arnsten AFT (1998) Catecholamine modulation of prefrontal cortical cognitive function. Trends Cogn Sci 2:436-447
4. Axelrod J, Tomchick R (1958) Enzymatic O-methylation of epinephrine and other catechols. J Biol Chem 233:702-705
5. Barbanti P, Fabbrini G, Ricci A, Cerbo R, Bronzetti E, Caronti B, Calderaro C, Felici L, Stocchi F, Meco G, Amenta F, Lenzi GL (1999) Increased expression of dopamine receptors on lymphocytes in Parkinson's disease. Mov Disord 14:764-771 (Pubitemid 29509618)
6. Basu S, Dasgupta PS (2000) Dopamine, a neurotransmitter, influences the immune system. J Neuroimmunol 102:113-124
7. Beck AT, Steer RA, Brown GK (1996) Manual for Beck Depression Inventory-II. Psychological Corporation, San Antonio, TX
8. Berridge KC, Robinson TE (1998) What is the role of dopamine in reward: hedonic impact, reward learning, or incentive salience? Brain Res Rev 28:309-369
9. Beuten J, Payne TJ, Ma JZ, Li MD (2005) Significant association of catechol-O-methyltransferase (COMT) haplotypes with nicotine dependence in male and female smokers of two ethnic populations. Neuropsychopharmacology 31:675-684
10. Booth BM, Leukefeld C, Falck R, Wang JC, Carlson R (2006) Correlates of rural methamphetamine and cocaine users: results from a multistate community study. J Stud Alcohol 67:493-501 (Pubitemid 43856724)
11. Buckley TC, Parker JD, Heggie J (2001) A psychometric evaluation of the BDI-II in treatment-seeking substance abusers. J Subst Abuse Treat 20:197-204 (Pubitemid 32552040)
12. Caronti B, Calderaro C, Passarelli F, Palladini G, Pontieri FE (1998) Dopamine receptor mRNAs in the rat lymphocytes. Life Sci 62:1919-1925 (Pubitemid 28234299)
13. Catnacho-Ochoa M, Walker EL, Evans DL, Piercey MF (1995) Rat brain binding sites for pramipexole, a clinically useful D3- preferring dopamine agonist. Neurosci Lett 196:97-100
14. Champion MC (1988) Domperidone. Gen Pharmacol Vasc Syst 19:499-505
15. Clark L, Robbins TW, Ersche KD, Sahakian BJ (2006) Reflection impulsivity in chronic and former substance users. Biol Psychiatry 60:512-522
16. Clatworthy PL, Lewis SJG, Brichard L, Hong YT, Izquierdo D, Clark L, Cools R, Aigbirhio FI, Baron JC, Fryer TD, Robbins TW (2009) Dopamine release in dissociable striatal subregions predicts the different effects of oral methylphenidate on reversal learning and spatial working memory. J Neurosci 29:4690-4696
17. Cools R, Sheridan M, Jacobs E, D'Esposito M (2007) Impulsive personality predicts dopamine-dependent changes in frontostriatal activity during component processes of working memory. J Neurosci 27:5506-5514 (Pubitemid 46790174)
18. Cools R, Frank MJ, Gibbs SE, Miyakawa A, Jagust W, D'Esposito M (2009) Striatal dopamine predicts outcome-specific reversal learning and its sensitivity to dopaminergic drug administration. J Neurosci 29:1538-1543
19. Czermak C, Lehofer M, Wagner EM, Prietl B, Lemonis L, Rohrhofer A, Schauenstein K, Liebmann PM (2004) Reduced dopamine D4 receptor mRNA expression in lymphocytes of long-term abstinent alcohol and heroin addicts. Addiction 99:251-257 (Pubitemid 38250759)
20. Ersche KD, Sahakian BJ (2007) The neuropsychology of amphetamine and opiate dependence: implications for treatment. Neuropsychology Review 17(3):317-336 (Pubitemid 47498176)
21. Ersche KD, Clark L, London M, Robbins TW, Sahakian BJ (2006) Profile of executive and memory function associated with amphetamine and opiate dependence. Neuropsychopharmacology 31:1036-1047
22. Ersche KD, Bullmore ET, Craig KJ, Shabbir SS, Abbott S,Muller U, Ooi C, Suckling J, Barnes A, Sahakian BJ,Merlo-Pich EV, Robbins TW (2010) Influence of compulsivity of drug abuse on dopaminergic modulation of attentional bias in stimulant dependence. Arch Gen Psychiatry 67:632-644
23. Eskandari F, Sternberg EM (2002) Neural-immune interactions in health and disease. Ann NY Acad Sci 966:20-27 (Pubitemid 34729157)
24. Everitt BJ, Robbins TW (2005) Neural systems of reinforcement for drug addiction: from actions to habits to compulsion. Nat Neurosci 8:1481-1489 (Pubitemid 41573659)
25. First MB, Spitzer RL, Gibbon M, Williams JBW (2002) Structured clinical interview for DSM-IV-TR Axis I Disorders, Research Version, Non-patient Edition. (SCID-I/NP). Biometrics Research, New York State Psychiatric Institute, New York
26. Foll BL, Gallo A, Strat YL, Lu L, Gorwood P (2009) Genetics of dopamine receptors and drug addiction: a comprehensive review. Behav Pharmacol 20:1-17, Review
27. Gladkevich A, Kauffman HF, Korf J (2004) Lymphocytes as a neural probe: potential for studying psychiatric disorders. Prog Neuro Psychopharmacol Biol Psychiatry 28:559-576 (Pubitemid 38490769)
28. Goldstein RZ, Volkow ND (2002) Drug addiction and its underlying neurobiological basis: neuroimaging evidence for the involvement of the frontal cortex. Am J Psychiatry 159:1642-1652
29. Goodarzi A, Vousooghi N, Sedaghati M, Mokri A, Zarrindast MR (2009) Dopamine receptors in human peripheral blood lymphocytes: changes in mRNA expression in opioid addiction. Eur J Pharmacol 615:218-222
30. Grabowski J, Shearer J, Merrill J, Negus SS (2004) Agonist-like, replacement pharmacotherapy for stimulant abuse and dependence. Addict Behav 29:1439-1464 (Pubitemid 39172183)
31. Green MF (1996) What are the functional consequences of neurocognitive deficits in schizophrenia? Am J Psychiatry 153:321-330
32. Harrison J, Owen AM (2001) Cognitive deficits in brain disorders. Informa Healthcare, London, U.K
33. Howell DC (1997) Statistical methods for psychology, 4th edn. Duxbury Press, London
34. Ilani T, Ben-Shachar D, Strous RD, Mazor M, Sheinkman A, Kotler M, Fuchs S (2001) A peripheral marker for schizophrenia: increased levels of D3 dopamine receptor mRNA in blood lymphocytes. Proc Natl Acad Sci USA 98:625-628 (Pubitemid 32105093)
35. Kelley AE, Berridge KC (2002) The neuroscience of natural rewards: relevance to addictive drugs. J Neurosci 22:3306-3311 (Pubitemid 37465733)
36. Kimberg DY, Aguirre GK, Lease J, D'Esposito M (2001) Cortical effects of bromocriptine, a D-2 dopamine receptor agonist, in human subjects, revealed by fMRI. Hum Brain Mapp 12:246-257 (Pubitemid 32238561)
37. Kirillova GP, Hrutkay RJ, Shurin MR, Shurin GV, Tourkova IL, Vanyukov MM(2008) Dopamine receptors in human lymphocytes: radioligand binding and quantitative RT-PCR assays. J Neurosci Meth 174:272-280
38. Koob GF (1992) Neural mechanisms of drug reinforcement. Ann NY Acad Sci 654:171-191
39. Li T, Chen CK, Hu X, Ball D, Lin SK, Chen W, Sham PC, Loh EW, Murray RM, Collier DA (2004) Association analysis of the DRD4 and COMT genes in methamphetamine abuse. Am J Med Genet B Neuropsychiatr Genet 129B:120-124
40. Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(T)(-delta delta C) method. Methods 25:402-408 (Pubitemid 34164012)
41. Lohoff FW, Weller AE, Bloch PJ, Nall AH, Ferraro TN, Kampman KM, Pettinati HM, Oslin DW, Dackis CA, O'Brien CP, Berrettini WH (2008) Association between the catechol-O-methyltransferase Val158Met polymorphism and cocaine dependence. Neuropsychopharmacology 33:3078-3084
42. Martinez D, Broft A, Foltin RW, Slifstein M, Hwang DR, Huang YY, Perez A, Frankel WG, Cooper T, Kleber HD, Fischman MW, Laruelle M (2004) Cocaine dependence and D-2 receptor availability in the functional subdivisions of the striatum: relationship with cocaine-seeking behavior. Neuropsychopharmacology 29:1190-1202 (Pubitemid 38670055)
43. Meador-Woodruff JH, Damask SP, Wang JC, Haroutunian V, Davis KL, Watson SJ (1996) Dopamine receptor mRNA expression in human striatum and neocortex. Neuropsychopharmacology 15:17-29 (Pubitemid 26233387)
44. Mehta MA, Owen AM, Sahakian BJ, Mavaddat N, Pickard JD, Robbins TW (2000) Methylphenidate enhances working memory by modulating discrete frontal and parietal lobe regions in the human brain. J Neurosci 20:RC65
45. Moeller FG, Barratt ES, Dougherty DM, Schmitz JM, Swann AC (2001) Psychiatric aspects of impulsivity. Am J Psychiatry 158:1783-1793 (Pubitemid 33054770)
46. Nader MA, Daunais JB, Moore T, Nader SH, Moore RJ, Smith HR, Friedman DP, Porrino LJ (2002) Effects of cocaine selfadministration on striatal dopamine systems in rhesus monkeys: initial and chronic exposure. Neuropsychopharmacology 27:35-46 (Pubitemid 34626741)
47. Nagai Y, Ueno S, Saeki Y, Soga F, Hirano M, Yanagihara T (1996) Decrease of the D3 dopamine receptor mRNA expression in lymphocytes from patients with Parkinson's disease. Neurology 46:791-795 (Pubitemid 26099651)
48. Nelson HE (1982) National Adult Reading Test Manual. NFERNelson, Windsor (UK)
49. Pacheco-Lopez G, Niemi MB, Kou W, Bildhauser A, Gross CM, Goebel MU, del Rey A, Besedovsky HO, Schedlowski M (2003) Central catecholamine depletion inhibits peripheral lymphocyte responsiveness in spleen and blood. J Neurochem 86:1024-1031 (Pubitemid 36988813)
50. Patton JH, Stanford MS, Barratt ES (1995) Factor structure of the Barratt Impulsiveness Scale. J Clin Psychol 51:768-774 (Pubitemid 26021724)
51. Robbins TW, Arnsten AFT (2009) The neuropsychopharmacology of fronto-executive function: monoaminergic modulation. Annu Rev Neurosci 32:267-287
52. Robbins TW, James M, Owen AM, Sahakian BJ, Mcinnes L, Rabbitt P (1994) Cambridge Neuropsychological Test Automated Battery (CANTAB) - a factor-analytic study of a large-sample of normal elderly volunteers. Dementia 5:266-281 (Pubitemid 24231105)
53. Rogers RD, Robbins TW (2003) The neuropsychology of chronic drug abuse. In: Ron MA, Robbins TW (eds) Disorders of brain and mind: vols 2. Cambridge University Press, Cambridge, pp 447-467
54. Sahakian BJ, Morris RG, Evenden JL, Heald A, Levy R, Philpot M, Robbins TW (1988) A comparative-study of visuospatial memory and learning in Alzheimer-type dementia and Parkinson's-disease. Brain 111:695-718
55. Schultz W (1997) Dopamine neurons and their role in reward mechanisms. Curr Opin Neurobiol 7:191-197
56. Segal DM, Moraes CT, Mash DC (1997) Up-regulation of D3 dopamine receptor mRNA in the nucleus accumbens of human cocaine fatalities. Mol Brain Res 45:335-339 (Pubitemid 27170712)
57. Shearer J, Sherman J, Wodak A, Van Beek I (2002) Substitution therapy for amphetamine users. Drug Alcohol Rev 21:179-185
58. Silver H, Feldman P, Bilker W, Gur RC (2003) Working memory deficit as a core neuropsychological dysfunction in schizophrenia. Am J Psychiatry 160:1809-1816 (Pubitemid 41103315)
59. Sladek-Chelgren S, Weinshilboum RM (1981) Catechol-Omethyltransferase biochemical genetics - human-lymphocyte enzyme. Biochem Genet 19:1037-1053 (Pubitemid 12183411)
60. Soares BG, Lima MS, Reisser AA, Farrell M (2004) Dopamine agonists for cocaine dependence. Cochane Database Syst.Rev. 1-45
61. Staley JK, Mash DC (1996) Adaptive increase in D-3 dopamine receptors in the brain reward circuits of human cocaine fatalities. J Neurosci 16:6100-6106 (Pubitemid 26313985)
62. Sullivan PF, Fan C, Perou CM (2006) Evaluating the comparability of gene expression in blood and brain. Am J Med Genet B Neuropsychiatr Genet 141B:261-268
63. Suzuki M, Hurd YL, Sokoloff P, Schwartz JC, Gr S (1998) D3 dopamine receptor mRNA is widely expressed in the human brain. Brain Res 779:58-74 (Pubitemid 28039940)
64. Tarazi FI, Baldessarini RJ (1999) Dopamine D-4 receptors: significance for molecular psychiatry at the millennium. Mol Psychiatry 4:529-538
65. Tunbridge EM, Bannerman DM, Sharp T, Harrison PJ (2004) Catechol-O-methyltransferase inhibition improves set-shifting performance and elevates stimulated dopamine release in the rat prefrontal cortex. J Neurosci 24:5331-5335 (Pubitemid 38747674)
66. Vandenbergh DJ, Rodriguez LA, Miller IT, Uhl GR, Lachman HM (1997) High-activity catechol-O-methyltransferase allele is more prevalent in polysubstance abusers. Am J Med Genet 74:439-442
67. Volkow ND, Fowler JS, Wang GJ, Hitzemann R, Logan J, Schlyer DJ, Dewey SL, Wolf AP (1993) Decreased dopamine-D(2) receptor availability is associated with reduced frontal metabolism in cocaine abusers. Synapse 14:169-177 (Pubitemid 23157765)
68. Volkow ND, Chang L, Wang GJ, Fowler JS, Ding YS, Sedler M, Logan J, Franceschi D, Gatley J, Hitzemann R, Gifford A, Wong C, Pappas N (2001) Low level of brain dopamine D-2 receptors in methamphetamine abusers: association with metabolism in the orbitofrontal cortex. Am J Psychiatry 158:2015-2021 (Pubitemid 33104107)
69. Wechsler D (1981) The psychometric tradition - developing the Wechsler Adult Intelligence Scale. Contemp Educ Psychol 6:82-85
70. Wise RA, Bozarth MA (1987) A psychomotor stimulant theory of addiction. Psychol Rev 94:469-492